HB 483

SUBCOMMITTEE

1. Line 64, introduced, after centers,

strike

or

insert

and

SUBCOMMITTEE

2. At the beginning of line 236, introduced

strike

independent

SUBCOMMITTEE

3. Line 263, introduced, after have

strike

the remainder of line 263 and through have on line 264

insert

(i) been on the market for at least three years; (ii) a wholesale acquisition cost that is not 20 percent or more lower than the referenced brand biologic wholesale acquisition cost at the time of the biosimilar launch; and (iii)

SUBCOMMITTEE

4. Line 322, introduced, after amount.

strike

the remainder of line 322, all of lines 323, 324, and 325, and through amount. on line 326